Pharmacogenomics: Harbinger for the era of personalized medicine?

Molecular Interventions

Volumn 5, Issue 3, 2005, Pages 140-143

  Sadée, Wolfgang ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST; DRUG RESEARCH; DRUG TARGETING; HUMAN; MEDICAL INFORMATICS; PHARMACOGENETICS; PHARMACOGENOMICS; SHORT SURVEY;

DELIVERY OF HEALTH CARE; DRUG DESIGN; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS;

EID: 22544461670     PISSN: 15340384     EISSN: None     Source Type: Journal    
DOI: 10.1124/mi.5.3.1     Document Type: Short Survey

References (2)

1. Lazarou, J., Pomeranz, B.H., and Corey, P.N. Incidence of adverse drug reactions in hospitalized patients. J. Amer. Med. Assn. 279, 1200-1205 (1998).
2. Phillips, K.A., Veenstra, D.L., Oren, E., Lee, K., and Sadée, W. The potential role of pharmacogenomics in reducing adverse drug reactions: A systematic review. J. Amer. Med. Assn. 286, 2270-2279 (2001).